1. Home
  2. ZURA vs LIEN Comparison

ZURA vs LIEN Comparison

Compare ZURA & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • LIEN
  • Stock Information
  • Founded
  • ZURA 2022
  • LIEN 2021
  • Country
  • ZURA United States
  • LIEN United States
  • Employees
  • ZURA N/A
  • LIEN N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • LIEN
  • Sector
  • ZURA Health Care
  • LIEN
  • Exchange
  • ZURA Nasdaq
  • LIEN NYSE
  • Market Cap
  • ZURA 292.1M
  • LIEN 292.1M
  • IPO Year
  • ZURA N/A
  • LIEN 2022
  • Fundamental
  • Price
  • ZURA $2.58
  • LIEN $12.54
  • Analyst Decision
  • ZURA Buy
  • LIEN
  • Analyst Count
  • ZURA 6
  • LIEN 0
  • Target Price
  • ZURA $15.80
  • LIEN N/A
  • AVG Volume (30 Days)
  • ZURA 712.8K
  • LIEN 8.2K
  • Earning Date
  • ZURA 11-07-2024
  • LIEN 11-07-2024
  • Dividend Yield
  • ZURA N/A
  • LIEN 8.69%
  • EPS Growth
  • ZURA N/A
  • LIEN N/A
  • EPS
  • ZURA N/A
  • LIEN 0.67
  • Revenue
  • ZURA N/A
  • LIEN $12,681,914.00
  • Revenue This Year
  • ZURA N/A
  • LIEN N/A
  • Revenue Next Year
  • ZURA N/A
  • LIEN N/A
  • P/E Ratio
  • ZURA N/A
  • LIEN $18.80
  • Revenue Growth
  • ZURA N/A
  • LIEN 22.94
  • 52 Week Low
  • ZURA $2.00
  • LIEN $7.29
  • 52 Week High
  • ZURA $6.35
  • LIEN $13.38
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 46.82
  • LIEN N/A
  • Support Level
  • ZURA $2.35
  • LIEN N/A
  • Resistance Level
  • ZURA $2.64
  • LIEN N/A
  • Average True Range (ATR)
  • ZURA 0.27
  • LIEN 0.00
  • MACD
  • ZURA 0.07
  • LIEN 0.00
  • Stochastic Oscillator
  • ZURA 75.44
  • LIEN 0.00

About ZURA Zura Bio Limited

Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

About LIEN CHICAGO ATLANTIC BDC INC

Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.

Share on Social Networks: